Join Bedfont® Scientific Limited & Heart of Kent Hospice for their Bluebell Walk 2024, on Sunday, 5th May.

A novel treatment that reprograms tumors to make them more responsive to immunotherapy showed promising activity in a preliminary clinical study of triple-negative breast cancer.

The No­vo Nordisk Foun­da­tion, the ma­jor­i­ty own­er of No­vo Nordisk, plans to put more mon­ey in­to re­gen­er­a­tive med­i­cines, in­clud­ing stem cells and cell ther­a­pies for